Total Funding
78
82
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42208
BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.
- Jason Matuszewski: Co-Founder
- Barry Hassett: Chief Commercial OfficerPast Role: BioStem Technologies, Senior Vice-President of Commercial Strategy
About the Company
BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe, and Mexico. Their goal is to deliver the highest standard of wellness and stem cell products that are backed by science. Through scientific studies, they seek to become a world leader in the wellness arena. This
will be accomplished by using high-quality nutraceuticals and stem cells. Their state-of-the-art laboratory is the first significant step in their quest to introduce the world and our shareholders to their dedication to delivering well-being.
